form10q.htm


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D. C. 20549
 





FORM 10-Q
 





 
x
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
 
For the quarterly period ended March 31, 2013

OR
 
¨
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from              to             

Commission file number 001-12019

 
QUAKER CHEMICAL CORPORATION
(Exact name of Registrant as specified in its charter)





 
     
Pennsylvania
 
23-0993790
(State or other jurisdiction of
incorporation or organization)
 
(I.R.S. Employer
Identification No.)
 
     
One Quaker Park, 901 E. Hector Street,
Conshohocken, Pennsylvania
 
19428 – 2380
(Address of principal executive offices)
 
(Zip Code)

Registrant’s telephone number, including area code: 610-832-4000

Not Applicable
Former name, former address and former fiscal year, if changed since last report.
 






Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes   x     No   ¨

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).Yes   x     No   ¨

Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.


 
Large accelerated filer  ¨    
 
Accelerated filer  x
 
 
Non-accelerated filer  ¨ (Do not check if smaller reporting company)
Smaller reporting Company ¨
 



Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes  ¨    No  x

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.
 
     
Number of Shares of Common Stock
Outstanding on March 31, 2013
 
 
13,139,691



 
 

 

QUAKER CHEMICAL CORPORATION AND CONSOLIDATED SUBSIDIARIES
 
         
 
  
 
  
Page
PART I.
  
FINANCIAL INFORMATION
  
 
Item 1.
  
Financial Statements (unaudited)
  
 
 
  
  
3
 
  
  
4
     
5
 
  
  
6
 
  
  
7
Item 2.
  
  
21
Item 3.
  
  
25
Item 4.
  
  
26
PART II.
  
  
27
Item 1.
   
27
Item 2.
   
27
Item 6.
  
  
28
Signatures
  
28

 
2

 
Table of Contents

PART I
FINANCIAL INFORMATION

Item 1.                                Financial Statements (Unaudited).

Quaker Chemical Corporation
 
Condensed Consolidated Balance Sheet

 
 

   
Unaudited
 
   
(Dollars in thousands,
 
   
except par value
 
   
and share amounts)
 
   
March 31, 2013
   
December 31, 2012*
 
 
 
ASSETS
 
 
 
 
 
 
 
 
Current assets
 
 
 
 
 
 
 
 
        Cash and cash equivalents
 
$
35,256 
 
 
$
32,547 
 
        Accounts receivable, net
 
 
157,163 
 
 
 
154,197 
 
        Inventories
 
 
   
 
 
   
                Raw materials and supplies
 
 
40,100 
 
 
 
40,417 
 
                Work-in-process and finished goods
 
 
33,865 
 
 
 
32,054 
 
        Prepaid expenses and other current assets
 
 
17,763 
 
 
 
18,595 
 
                Total current assets
 
 
284,147 
 
 
 
277,810 
 
Property, plant and equipment, at cost
 
 
226,170 
 
 
 
225,177 
 
        Less accumulated depreciation
 
 
(141,242)
   
 
(140,065)
 
                Net property, plant and equipment
 
 
84,928 
 
 
 
85,112 
 
Goodwill
 
 
59,248 
 
 
 
59,169 
 
Other intangible assets, net
 
 
32,972 
 
 
 
32,809 
 
Investments in associated companies
 
 
15,605 
 
 
 
16,603 
 
Deferred income taxes
 
 
28,935 
 
 
 
30,673 
 
Other assets
 
 
34,752 
 
 
 
34,458 
 
                Total assets
 
$
540,587 
 
 
$
536,634 
 
 
 
 
   
 
 
   
LIABILITIES AND EQUITY
 
 
   
 
 
   
Current liabilities
 
 
   
 
 
   
        Short-term borrowings and current portion of long-term debt
 
$
1,905 
 
 
$
1,468 
 
        Accounts and other payables
 
 
74,807 
 
 
 
70,794 
 
        Accrued compensation
 
 
11,016 
 
 
 
16,842 
 
        Other current liabilities
 
 
25,280 
 
 
 
18,688 
 
               Total current liabilities
 
 
113,008 
 
 
 
107,792 
 
Long-term debt
 
 
27,675 
 
 
 
30,000 
 
Deferred income taxes
 
 
6,256 
 
 
 
6,383 
 
Other non-current liabilities
 
 
91,675 
 
 
 
102,783 
 
               Total liabilities
 
 
238,614 
 
 
 
246,958 
 
Equity
 
 
   
 
 
   
         Common stock $1 par value; authorized 30,000,000 shares; issued and outstanding
 
 
   
 
 
   
            2013 – 13,139,691 shares; 2012 – 13,094,901 shares
   
13,140 
     
13,095 
 
         Capital in excess of par value
 
 
95,775 
 
 
 
94,470 
 
         Retained earnings
 
 
225,790 
 
 
 
215,390 
 
         Accumulated other comprehensive loss
 
 
(41,747)
   
 
(41,855)
 
               Total Quaker shareholders’ equity
 
 
292,958 
 
 
 
281,100 
 
Noncontrolling interest
   
9,015 
     
8,576 
 
Total equity
   
301,973 
     
289,676 
 
         Total liabilities and equity
 
$
540,587 
 
 
$
536,634 
 


*
Condensed from audited financial statements

The accompanying notes are an integral part of these condensed consolidated financial statements.

 
3

 
Table of Contents

Quaker Chemical Corporation
 
Condensed Consolidated Statement of Income
 
   
Unaudited
 
   
(Dollars in thousands,
 
   
except per share amounts)
 
   
Three Months Ended March 31,
 
   
2013
   
2012
 
Net sales
  $ 176,193     $ 177,638  
Cost of goods sold
    113,585       117,843  
Gross profit
    62,608       59,795  
Selling, general and administrative expenses
    45,197       43,093  
Operating income
    17,411       16,702  
Other income, net
    346       341  
Interest expense
    (744 )     (1,174 )
Interest income
    169       123  
Income before taxes and equity in net income of associated companies
    17,182       15,992  
Taxes on income before equity in net income of associated companies
    4,133       3,445  
Income before equity in net income of associated companies
    13,049       12,547  
Equity in net income of associated companies
    1,142       565  
Net income
    14,191       13,112  
Less: Net income attributable to noncontrolling interest
    572       747  
Net income attributable to Quaker Chemical Corporation
  $ 13,619     $ 12,365  
Per share data:
               
Net income attributable to Quaker Chemical Corporation Common Shareholders – basic
  $ 1.04     $ 0.96  
Net income attributable to Quaker Chemical Corporation Common Shareholders – diluted
  $ 1.04     $ 0.95  
Dividends declared
  $ 0.245     $ 0.24  

The accompanying notes are an integral part of these condensed consolidated financial statements.

 
4

 
Table of Contents

Quaker Chemical Corporation
 
Condensed Consolidated Statement of Comprehensive Income


   
Unaudited
 
   
(Dollars in thousands)
 
   
Three Months Ended March 31,
 
   
2013
   
2012
 
Net income
  $ 14,191     $ 13,112  
                 
Other comprehensive (loss) income, net of tax
               
Currency translation adjustments
    (1,763 )     4,048  
Defined benefit retirement plans
    1,306       57  
Current period change in fair value of derivatives
          96  
Unrealized gain on available-for-sale securities
    432       1,078  
Other comprehensive (loss) income
    (25 )     5,279  
                 
Comprehensive income
    14,166       18,391  
Less: comprehensive income attributable to noncontrolling interest
    (439 )     (1,038 )
Comprehensive income attributable to Quaker Chemical Corporation
  $ 13,727     $ 17,353  

The accompanying notes are an integral part of these condensed consolidated financial statements.

 
5

 
Table of Contents


Quaker Chemical Corporation
 
Condensed Consolidated Statement of Cash Flows

   
Unaudited
 
   
(Dollars in thousands)
 
   
For the Three Months Ended
 
   
March 31,
 
   
2013
   
2012
 
Cash flows from operating activities
           
Net income
  $ 14,191     $ 13,112  
Adjustments to reconcile net income to net cash provided by operating activities:
               
Depreciation
    3,056       3,057  
Amortization
    879       746  
Equity in undistributed earnings of associated companies, net of dividends
    921       (381 )
Deferred compensation and other, net
    (861 )     (103 )
Stock-based compensation
    1,040       1,186  
Gain on disposal of property, plant and equipment
    (2 )     (14 )
Insurance settlement realized
          (483 )
Pension and other postretirement benefits
    (2,521 )     (2,357 )
(Decrease) increase in cash from changes in current assets and current liabilities, net of acquisitions:
               
Accounts receivable
    (3,977 )     (9,764 )
Inventories
    (1,837 )     352  
Prepaid expenses and other current assets
    (457 )     (557 )
Accounts payable and accrued liabilities
    874       1,938  
Net cash provided by operating activities
    11,306       6,732  
                 
Cash flows from investing activities
               
Investments in property, plant and equipment
    (2,723 )     (3,178 )
Payments related to acquisitions, net of cash acquired
    (647 )      
Proceeds from disposition of assets
    13       64  
Insurance settlement received and interest earned
    14       18  
Change in restricted cash, net
    (14 )     465  
Net cash used in investing activities
    (3,357 )     (2,631 )
                 
Cash flows from financing activities
               
Net increase in short-term borrowings
    594        
Proceeds from long-term debt
          1,350  
Repayment of long-term debt
    (2,438 )     (189 )
Dividends paid
    (3,208 )     (3,105 )
Stock options exercised, other
    (59 )     (1,288 )
Excess tax benefit related to stock option exercises
    369       546  
Net cash used in financing activities
    (4,742 )     (2,686 )
Effect of exchange rate changes on cash
    (498 )     640  
Net increase in cash and cash equivalents
    2,709       2,055  
Cash and cash equivalents at beginning of period
    32,547       16,909  
Cash and cash equivalents at end of period
  $ 35,256     $ 18,964  
                 
Supplemental cash flow disclosures:
               
Non-cash activities:
               
Excess tax benefit related to stock option exercises
  $     $ 706  

The accompanying notes are an integral part of these condensed consolidated financial statements.

 
6

Quaker Chemical Corporation
Notes to Condensed Consolidated Financial Statements
(Dollars in thousands, except per share amounts)
(Unaudited)


Note 1 – Condensed Financial Information
 
The condensed consolidated financial statements included herein are unaudited and have been prepared in accordance with generally accepted accounting principles in the United States for interim financial reporting and the United States Securities and Exchange Commission regulations. Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles in the United States have been condensed or omitted pursuant to such rules and regulations. In the opinion of management, the financial statements reflect all adjustments (consisting only of normal recurring adjustments, except as discussed below) which are necessary for a fair statement of the financial position, results of operations and cash flows for the interim periods. Certain reclassifications of prior year data have been made to improve comparability.  The results for the three months ended March 31, 2013 are not necessarily indicative of the results to be expected for the full year. These financial statements should be read in conjunction with the Company’s Annual Report filed on Form 10-K for the year ended December 31, 2012.
 
During the first quarter of 2013, the Company adopted the Financial Accounting Standards Board’s (“FASB’s”) guidance regarding the disclosure of reclassifications from Accumulated Other Comprehensive Income (Loss) (“AOCI”).  The guidance requires the disclosure of significant amounts reclassified from each component of AOCI, the related tax amounts and the income statement line items affected by the reclassifications, either parenthetically on the Condensed Consolidated Statement of Comprehensive Income or in the Notes to the Condensed Consolidated Financial Statements.  The Company elected to present the information in the Notes to the Condensed Consolidated Financial Statements, and the adoption of this guidance did not have a material impact on the Company’s results or financial condition.  See Note 9 of Notes to Condensed Consolidated Financial Statements.
 
Effective January 1, 2010, Venezuela’s economy was considered to be hyperinflationary under generally accepted accounting principles in the United States, as it had experienced a rate of general inflation in excess of 100% over the latest three-year period, based upon the blended Consumer Price Index and National Consumer Price Index.  Accordingly, all gains and losses resulting from the remeasurement of the Company’s Venezuelan 50% owned equity affiliate (Kelko Quaker Chemical, S.A.) were required to be recorded directly to the Condensed Consolidated Statement of Income.  On January 8, 2010, the Venezuelan government announced the devaluation of the Bolivar Fuerte and the establishment of a two-tiered exchange structure.  In February 2013, the Venezuelan Government announced a further devaluation of the Bolivar Fuerte.  Accordingly, the Company recorded a charge of approximately $0.03 per diluted share during the first quarter of 2013.
 
As part of the Company’s chemical management services, certain third-party product sales to customers are managed by the Company. Where the Company acts as the principal, revenue is recognized on a gross reporting basis at the selling price negotiated with customers. Where the Company acts as an agent, such revenue is recorded using net reporting as service revenues, at the amount of the administrative fee earned by the Company for ordering the goods. Third-party products transferred under arrangements resulting in net reporting totaled $8,778 and $11,229 for the three months ended March 31, 2013 and March 31, 2012, respectively.
 
Note 2 – Out of Period Adjustment
 
As previously disclosed in the Company’s 2012 Annual Report on Form 10-K, the Company had reassessed its ability to significantly influence the operating and financial policies of its captive insurance equity affiliate, Primex.  Based on its ownership percentage and other factors, the Company determined that, during 2012, the Company obtained the ability to significantly influence Primex and, as a result, changed its method of accounting from the cost to equity method.   During the first quarter of 2013, the Company identified errors in Primex’s estimated 2012 financial statements, which primarily related to a reinsurance contract held by Primex.  The identified errors resulted in a cumulative $1,038 understatement of the Company’s equity in net income from associated companies for the year ended December 31, 2012.  The Company corrected the errors related to Primex in the first quarter of 2013, which had the net effect of increasing equity in net income from associated companies by $1,038 for the three months ended March 31, 2013.  The Company does not believe this adjustment is material to the consolidated financial statements for the year ended December 31, 2012 or to the Company’s projected results for the current year and, therefore, has not restated any prior period amounts.  As the Company’s assessment was based on projected full year 2013 results, the Company will update its assessment at year-end based upon actual 2013 results.
 
Note 3 – Income Taxes and Uncertain Income Tax Positions
 
The Company’s first quarter of 2013 effective tax rate was 24.1%, as compared to an effective tax rate of 21.5% for the first quarter of 2012.  Both quarters’ effective tax rates reflect decreases in reserves for uncertain tax positions due to the expiration of applicable statutes of limitations for certain tax years of approximately $0.10 and $0.12 per diluted share for the three months ended March 31, 2013 and March 31, 2012, respectively.  Also, contributing to the difference in the effective tax rate is that the tax rate in China was 15% in 2012 compared to 25% in the first quarter of 2013.  While the Company's re-certification of its Chinese subsidiary as a high tech enterprise is pending, the Company will record tax expense at the statutory rate of 25%.
 

 
7

Quaker Chemical Corporation
Notes to Condensed Consolidated Financial Statements - Continued
(Dollars in thousands, except per share amounts)
(Unaudited)


As of March 31, 2013, the Company’s cumulative liability for gross unrecognized tax benefits was $10,924.  At December 31, 2012, the Company’s cumulative liability for gross unrecognized tax benefits was $12,410.
 
The Company continues to recognize interest and penalties associated with uncertain tax positions as a component of taxes on income before equity in net income of associated companies in its Condensed Consolidated Statement of Income. The Company recognized ($477) for interest and $93 for penalties on its Condensed Consolidated Statement of Income for the three months ended March 31, 2013, and ($215) for interest and $95 for penalties on its Condensed Consolidated Statement of Income during the three months ended March 31, 2012. As of March 31, 2013, the Company had accrued $1,764 for cumulative interest and $1,677 for cumulative penalties, compared to $2,288 for cumulative interest and $1,630 for cumulative penalties accrued at December 31, 2012.
 
During the three months ended March 31, 2013 and March 31, 2012, the Company recognized decreases of approximately $1,687 and $1,072, respectively, in its cumulative liability for gross unrecognized tax benefits due to the expriation of the applicable statutes of limitations for certain tax years.
 
The Company estimates that during the year ending December 31, 2013 it will reduce its cumulative liability for gross unrecognized tax benefits by approximately $2,400 to $2,500 due to the expiration of the statute of limitations for certain tax years. This estimated reduction in the cumulative liability for unrecognized tax benefits does not consider any increase in liability for unrecognized tax benefits with regard to existing tax positions or any increase in cumulative liability for unrecognized tax benefits with regard to new tax positions for the year ending December 31, 2013.
 
The Company and its subsidiaries are subject to U.S. Federal income tax, as well as the income tax of various state and foreign tax jurisdictions. Tax years that remain subject to examination by major tax jurisdictions include the Netherlands and the United Kingdom from 2007, Brazil and Spain from 2008, the United States from 2009, China and Italy from 2010, and various domestic state tax jurisdictions from 1993.
 
In the first quarter of 2013, the Internal Revenue Service (“IRS”) initiated a limited scope audit of the Company’s 2010 Federal Income Tax Return.  By letter dated March 25, 2013, the IRS notified the Company that it had completed the review of the Company’s 2010 Federal Income Tax Return without any changes to the reported tax.
 
During the second quarter of 2012, the Italian tax authorities initiated a transfer pricing audit of the Company’s Italian subsidiary.  On July 7, 2012, the Company received a preliminary tax report related to this transfer pricing audit, which proposed several adjustments to the taxable income of the subsidiary.  During the fourth quarter of 2012, the Company’s Italian subsidiary received an assessment for the tax year 2007, which the Company appealed during the first quarter of 2013.  In conjunction with outside counsel, the Company reviewed the report and believes it should prevail on its merits.  The Company does not believe it has any exposures warranting an uncertain tax position reserve as of March 31, 2013.
 
At the end of March 2013, the Chinese tax authorities announced they would be reviewing the original applications of all companies that were certified as high tech enterprises in Shanghai.  If the tax authorities find significant issues with the application, they could disallow the benefits of high tech enterprise status retroactively.  The Company currently understands that a retroactive disallowance of the high tech enterprise status would affect only 2012.  Currently, no appointment with the tax auditor has been scheduled.  The Company does not believe that its status as a high tech enterprise will be revoked and as a result no uncertain tax position has been recorded.
 

 
8

Quaker Chemical Corporation
Notes to Condensed Consolidated Financial Statements - Continued
(Dollars in thousands, except per share amounts)
(Unaudited)


Note 4 – Fair Value Measurements
 
The Company values its company-owned life insurance policies, various deferred compensation assets and liabilities, acquisition-related consideration and an obligation related to a non-competition agreement at fair value.  The Company’s assets and liabilities subject to fair value measurement are as follows (in thousands):

         
Fair Value Measurements at March 31, 2013
 
   
Fair Value
   
Using Fair Value Hierarchy
 
   
as of
                   
Assets
 
March 31, 2013
   
Level 1
   
Level 2
   
Level 3
 
Company-owned life insurance
  $ 1,733     $     $ 1,733     $  
Company-owned life insurance - Deferred compensation assets
    398             398        
Other deferred compensation assets
                               
Large capitalization registered investment companies
    63       63              
Mid capitalization registered investment companies
    6       6              
Small capitalization registered investment companies
    10       10              
International developed and emerging markets registered investment
                               
                companies
    34       34              
Fixed income registered investment companies
    8       8              
                                 
Total
  $ 2,252     $ 121     $ 2,131     $  

         
Fair Value Measurements at March 31, 2013
 
   
Fair Value
   
Using Fair Value Hierarchy
 
   
as of
                   
Liabilities
 
March 31, 2013
   
Level 1
   
Level 2
   
Level 3
 
Deferred compensation liabilities
                       
Large capitalization registered investment companies
  $ 338     $ 338     $     $  
Mid capitalization registered investment companies
    93       93              
Small capitalization registered investment companies
    76       76              
International developed and emerging markets registered investment
                               
                  companies
    179       179              
Fixed income registered investment companies
    45       45              
Fixed general account
    161             161        
Acquisition-related consideration
    5,010                   5,010  
                                 
Total
  $ 5,902     $ 731     $ 161     $ 5,010  

         
Fair Value Measurements at December 31, 2012
 
   
Fair Value
   
Using Fair Value Hierarchy
 
   
as of
                   
Assets
 
December 31, 2012
   
Level 1
   
Level 2
   
Level 3
 
Company-owned life insurance
  $ 1,653     $     $ 1,653     $  
Company-owned life insurance - Deferred compensation assets
    437             437        
Other deferred compensation assets
                               
Large capitalization registered investment companies
    62       62              
Mid capitalization registered investment companies
    6       6              
Small capitalization registered investment companies
    9       9              
International developed and emerging markets registered investment
                               
                 companies
    37       37              
Fixed income registered investment companies
    8       8              
                                 
Total
  $ 2,212     $ 122     $ 2,090     $  

 
9

Quaker Chemical Corporation
Notes to Condensed Consolidated Financial Statements - Continued
(Dollars in thousands, except per share amounts)
(Unaudited)



         
Fair Value Measurements at December 31, 2012
 
   
Fair Value
   
Using Fair Value Hierarchy
 
   
as of
                   
Liabilities
 
December 31, 2012
   
Level 1
   
Level 2
   
Level 3
 
Deferred compensation liabilities
                       
Large capitalization registered investment companies
  $ 336     $ 336     $     $  
Mid capitalization registered investment companies
    88       88              
Small capitalization registered investment companies
    72       72              
International developed and emerging markets registered investment
                               
                 companies
    187       187              
Fixed income registered investment companies
    48       48              
Fixed general account
    173             173        
Acquisition-related consideration
    4,901                   4,901  
                                 
Total
  $ 5,805     $ 731     $ 173     $ 4,901  

The fair values of Company-owned life insurance (“COLI”) and COLI deferred compensation assets are based on quotes for like instruments with similar credit ratings and terms.  The fair values of other deferred compensation assets and liabilities are based on quoted prices in active markets.  The fair value of the Summit earnout is based on unobservable inputs and is classified as Level 3.  Significant inputs and assumptions are management’s estimate of the probability of the earnout ultimately being met/paid and the discount rate used to present value the liability.  The fair value of the obligation related to a non-competition agreement is also based on unobservable inputs and is classified as Level 3.  The significant input and assumption for the obligation related to the non-competition agreement is management’s estimate of the discount rate used to present value the liability.  Significant changes in any Level 3 assumption in isolation would result in increases or decreases to the fair value measurements for the earnout and the obligation related to the non-competition agreement.
 
Changes in the fair value of the Level 3 liabilities during the three months ended March 31, 2013 were as follows:

     
Non-competition
       
 
Earnout
 
Agreement
       
 
Summit
 
Obligation
 
Total
 
Balance at December 31, 2012
  $ 4,497     $ 404     $ 4,901  
Interest accretion
    163       8       171  
Payments
          (62 )     (62 )
Balance at March 31, 2013
  $ 4,660     $ 350     $ 5,010  

During the first quarter of 2013, the Summit earnout liability became current and was reclassified from other non-current liabilities to other current liabilities on the Company’s Condensed Consolidated Balance Sheet.
 
Quantitative information about the Company’s Level 3 fair value measurements at March 31, 2013 were as follows:

   
Fair value at
March 31, 2013
 
Valuation technique
Unobservable input
 
Input value
 
Summit earnout
  $ 4,660  
Discounted cash flow
Discount rate
    14.5 %
Non-competition agreement obligation
  $ 350  
Discounted cash flow
Discount rate
    14.0 %

The fair value of the Summit earnout is also based on the weighted average probability of the outcome of different payout scenarios.  As of March 31, 2013, the weighted average probabilities applied to the payout scenarios ranged from 20% to 50%, depending on the Company’s estimate of the likelihood of each payout scenario.
 
Note 5 – Hedging Activities
 
The Company utilized interest rate swaps to mitigate the impact of changes in interest rates by converting a portion of Company’s variable interest rate debt to fixed interest rate debt.  These interest rate swaps had a combined notional amount of $15,000 during 2012 until their maturity, which occurred during the third quarter of 2012.  The Company had no derivatives designated as cash flow hedges as of December 31, 2012 and did not utilize any during the three months ended March 31, 2013.
 

 
10

Quaker Chemical Corporation
Notes to Condensed Consolidated Financial Statements - Continued
(Dollars in thousands, except per share amounts)
(Unaudited)


Information about the Company’s former interest rate derivatives is as follows:

Cash Flow Hedges
 
Interest Rate Swaps
 
               
     
Three Months Ended
 
     
March 31,
 
     
2013
   
2012
 
               
Amount of Gain Recognized in Accumulated OCI on Derivative (Effective Portion)
    $     $ 96  
                   
Amount and Location of Loss Reclassified from Accumulated OCI into Income
                 
(Effective Portion)
Interest Expense
  $     $ (158 )
                   
Amount and Location of Loss Recognized in Income on Derivative (Ineffective
                 
Portion and Amount Excluded from Effectiveness Testing)
Other Income
  $     $  

Note 6 – Stock-Based Compensation
 
The Company recognized the following share based compensation expense in selling, general and administrative expenses in its Condensed Consolidated Statement of Income for the three months ended March 31, 2013 and the three months ended March 31, 2012:
 

   
March 31,
 
   
2013
   
2012
 
Stock options
  $ 100     $ 128  
Nonvested stock awards
    383       380  
Employee stock purchase plan
    12       11  
Non-elective and elective 401(k) matching contribution in stock
    525       652  
Director stock ownership plan
    20       15  
Total share-based compensation expense
  $ 1,040     $ 1,186  

As of March 31, 2013 and March 31, 2012, the Company recorded $369 and $1,252, respectively, of excess tax benefits in capital in excess of par value on its Condensed Consolidated Balance Sheets, related to stock option exercises. Based on estimated taxes payable, the Company recognized $369 and $546 of these benefits as cash inflows from financing activities in its Condensed Consolidated Statement of Cash Flows, which represented the Company’s estimate of cash savings through March 31, 2013 and March 31, 2012, respectively.
 
Stock option activity under all plans is as follows:

           
Weighted
        Weighted  
Average
     
Average
 
Remaining
 
Number of
 
Exercise Price
 
Contractual
 
Shares
 
 per Share
 
Term (years)
Options outstanding at December 31, 2012
107,455 
 
$
31.23 
   
Options granted
29,302 
   
58.26 
   
Options exercised
(20,433)
   
25.46 
   
Options forfeited
(3,601)
   
37.81 
   
Options outstanding at March 31, 2013
112,723 
 
$
39.09 
 
5.5 
Options exercisable at March 31, 2013
48,581 
 
$
28.01 
 
4.5 

As of March 31, 2013, the total intrinsic value of options outstanding was approximately $2,317, and the total intrinsic value of exercisable options was $1,536.  Intrinsic value is calculated as the difference between the current market price of the underlying security and the strike price of a related option.
 

 
11

Quaker Chemical Corporation
Notes to Condensed Consolidated Financial Statements - Continued
(Dollars in thousands, except per share amounts)
(Unaudited)


A summary of the Company’s outstanding stock options at March 31, 2013 is as follows: 

                 
Weighted
 
Weighted
 
 
 
Weighted
 
               
Number
Average
 
Average
 
Number
 
Average
 
 
Range of
 
Outstanding
Contractual
 
Exercise
 
Exercisable
 
Exercise
 
 
Exercise Prices
 
at 3/31/2013
Life
 
Price
 
at 3/31/2013
 
Price
 
 
$
0.00
-
 
$
10.00 
 
— 
— 
 
$
— 
 
— 
 
$
— 
 
 
$
10.01 
-
 
$
20.00 
 
24,858 
3.8 
   
18.82 
 
24,858 
   
18.82 
 
 
$
20.01 
-
 
$
30.00 
 
— 
— 
   
— 
 
— 
   
— 
 
 
$
30.01 
-
 
$
40.00 
 
56,371 
5.4 
   
37.78 
 
23,723 
   
37.65 
 
 
$
40.01 
-
 
$
50.00 
 
2,192 
6.3 
   
46.21 
 
— 
   
— 
 
 
$
50.01 
-
 
$
60.00 
 
29,302 
6.9 
   
58.26 
 
— 
   
— 
 
               
112,723 
5.5 
   
39.09 
 
48,581 
   
28.01 
 

As of March 31, 2013, unrecognized compensation expense related to options granted during 2011 was $135, for options granted during 2012 was $389 and for options granted in 2013 was $624.
 
During the first quarter of 2013, the Company granted stock options under its LTIP plan that are subject only to time vesting over a three-year period.  For the purposes of determining the fair value of stock option awards, the Company uses the Black-Scholes option pricing model and the assumptions set forth in the table below:

 
2013 
 
Number of options granted
 29,302 
 
Dividend Yield
2.49 
%
Expected Volatility
57.28 
%
Risk-free interest rate
0.63 
%
Expected term (years)
4.0 
 

Approximately $15 of expense was recorded on these options during the first three months of 2013.  The fair value of these awards is amortized on a straight-line basis over the vesting period of the awards.
 
Activity of nonvested shares granted under the Company’s LTIP plan is shown below:

     
Weighted
 
     
Average Grant
 
 
Number of
 
Date Fair Value
 
 
Shares
 
(per share)
 
Nonvested awards, December 31, 2012
122,944 
 
$
31.98 
 
Granted
26,611 
 
$
58.26 
 
Vested
(35,183)
 
$
20.25 
 
Forfeited
(1,761)
 
$
37.76 
 
Nonvested awards, March 31, 2013
112,611 
 
$
41.77 
 

The fair value of the nonvested stock is based on the trading price of the Company’s common stock on the date of grant. The Company adjusts the grant date fair value for expected forfeitures based on historical experience for similar awards.  As of March 31, 2013, unrecognized compensation expense related to these awards was $2,718 to be recognized over a weighted average remaining period of 2.43 years.
 
Activity of nonvested restricted stock units granted under the Company’s LTIP plan is shown below:
 
     
Weighted
 
     
Average Grant
 
 
Number of
 
Date Fair Value
 
 
units
 
(per unit)
 
Nonvested awards, December 31, 2012
2,100 
 
$
38.13 
 
Granted
1,418 
 
$
58.26 
 
Vested
— 
 
$
— 
 
Forfeited
— 
 
$
— 
 
Nonvested awards, March 31, 2013
3,518 
 
$
46.24 
 


 
12

Quaker Chemical Corporation
Notes to Condensed Consolidated Financial Statements - Continued
(Dollars in thousands, except per share amounts)
(Unaudited)


The fair value of the nonvested restricted stock units is based on the trading price of the Company’s common stock on the date of grant. The Company adjusts the grant date fair value for expected forfeitures based on historical experience for similar awards. As of March 31, 2013, unrecognized compensation expense related to these awards was $115 to be recognized over a weighted average remaining period of 2.61 years.
 
Employee Stock Purchase Plan
 
In 2000, the Board adopted an Employee Stock Purchase Plan (“ESPP”) whereby employees may purchase Company stock through a payroll deduction plan. Purchases are made from the plan and credited to each participant’s account at the end of each month, the “Investment Date.” The purchase price of the stock is 85% of the fair market value on the Investment Date. The plan is compensatory and the 15% discount is expensed on the Investment Date. All employees, including officers, are eligible to participate in this plan. A participant may withdraw all uninvested payment balances credited to a participant’s account at any time.  An employee whose stock ownership of the Company exceeds five percent of the outstanding common stock is not eligible to participate in this plan.
 
2003 Director Stock Ownership Plan
 
In March 2003, the Company’s Board of Directors adopted the 2003 Director Stock Ownership Plan (the “Plan”), subject to the approval by the Company’s shareholders at the annual meeting, to encourage the Directors to increase their investment in the Company. The Plan was effective on the date it was approved and remained in effect for a term of ten years or until it is earlier terminated by the Board.  The Plan expires in May 2013. The maximum number of shares of Common Stock which can be issued under the Plan was 75,000, subject to certain conditions that the Compensation/Management Development Committee (the “Committee”) may consider to adjust the number of shares. As of March 31, 2013, the Committee did not make any elections to adjust the shares under this plan. Under the Plan, each Director was eligible to receive an annual retainer for services rendered as a member of the Board of Directors. Each Director who owned less than 7,500 shares of Company Common Stock was required to receive 75% of the annual retainer in Common Stock and 25% of the annual retainer in cash.  Each Director who owned 7,500 or more shares of Company Common Stock may have elected to receive payment of a percentage (up to 100%) of the annual retainer in shares of common stock.  The annual retainer was $40.  The number of shares issued in payment of the fees was calculated based on an amount equal to the average of the closing prices per share of Common Stock as reported on the composite tape of the New York Stock Exchange for the two trading days immediately preceding the retainer payment date. The retainer payment date was June 1.
 
2013 Director Stock Ownership Plan
 
The 2013 Director Stock Ownership Plan (“2013 Plan”), which was adopted by the Company’s Board of Directors on March 6, 2013, subject to approval by the Company’s shareholders at the May 2013 annual meeting, authorizes the issuance of up to 75,000 shares of Quaker common stock in accordance with the terms of the 2013 Plan in payment of all or a portion of the annual cash retainer payable to each of the Company’s non-employee directors in 2013 and subsequent years during the term of the 2013 Plan.  Under the 2013 Plan, each director who, on May 1st of the applicable calendar year, owns less than 400% of the annual cash retainer for the applicable calendar year, divided by the average of the closing price of a share of Quaker Common Stock as reported by the composite tape of New York Stock Exchange for the previous calendar year (the “Threshold Amount”), is required to receive 75% of the annual cash retainer in common stock and 25% of the retainer in cash, unless the Director elects to receive a greater percentage of Quaker common stock (up to 100%) of the annual cash retainer for the applicable year.  Each director who owns more than the Threshold Amount may elect to receive common stock in payment of a percentage (up to 100%) of the annual cash retainer.  Under the 2013 Plan, the annual retainer is $50.  The 2013 Plan was adopted in order to replace the 2003 Director Stock Ownership Plan, which will expire in May 2013.
 

 
13

Quaker Chemical Corporation
Notes to Condensed Consolidated Financial Statements - Continued
(Dollars in thousands, except per share amounts)
(Unaudited)


Note 7 – Earnings Per Share
 
The following table summarizes earnings per share calculations for the three months ended March 31, 2013 and March 31, 2012:

   
Three Months Ended March 31,
 
   
2013
   
2012
 
Basic earnings per common share
           
             
Net income attributable to Quaker Chemical Corporation
  $ 13,619     $ 12,365  
Less: income allocated to participating securities
    (111 )     (200 )
Net income available to common shareholders
  $ 13,508     $ 12,165  
Basic weighted average common shares outstanding
    13,001,963       12,730,682  
                 
Basic earnings per common share
  $ 1.04     $ 0.96  
                 
Diluted earnings per common share
               
                 
Net income attributable to Quaker Chemical Corporation
  $ 13,619     $ 12,365  
Less: income allocated to participating securities
    (111 )     (198 )
Net income available to common shareholders
  $ 13,508     $ 12,167  
Basic weighted average common shares outstanding
    13,001,963       12,730,682  
Effect of dilutive securities
    29,937       121,210  
Diluted weighted average common shares outstanding
    13,031,900       12,851,892  
                 
Diluted earnings per common share
  $ 1.04     $ 0.95  

The following number of stock options and restricted stock units are not included in the diluted earnings per share calculation since the effect would have been anti-dilutive: 2,444 and 20,178 for the three months ended March 31, 2013 and March 31, 2012, respectively.
 
Note 8 – Business Segments
 
The following table presents information about the Company’s reported segments for the three months ended March 31, 2013 and March 31, 2012:
 

   
Three Months Ended
 
   
March 31,
 
   
2013
   
2012
 
Metalworking Process Chemicals
           
Net sales
  $ 164,936     $ 165,975  
Operating income for reportable segment
    32,027       30,975  
Coatings
               
Net sales
    10,746       10,523  
Operating income for reportable segment
    2,506       2,513  
Other Chemical Products
               
Net sales
    511       1,140  
Operating (loss) income for reportable segment
    (21 )     142  
Total
               
Net sales
    176,193       177,638  
Operating income for reportable segments
    34,512       33,630  
Non-operating expenses
    (16,222 )     (16,182 )
Amortization expense
    (879 )     (746 )
Consolidated operating income
    17,411       16,702  
Interest expense
    (744 )     (1,174 )
Interest income
    169       123  
Other income, net
    346       341  
Consolidated income before taxes and equity in net income of associated companies
  $ 17,182     $ 15,992  


 
14

Quaker Chemical Corporation
Notes to Condensed Consolidated Financial Statements - Continued
(Dollars in thousands, except per share amounts)
(Unaudited)


Operating income is comprised of revenue less related costs and expenses. Non-operating items primarily consist of general corporate expenses identified as not being a cost of operation, interest expense, interest income, and license fees from non-consolidated affiliates.
 
Note 9 – Equity and Noncontrolling Interest
 
The following table presents the changes in equity and noncontrolling interest, net of tax, for the three months ended March 31, 2013 and March 31, 2012:
 
                     
Accumulated
             
         
Capital in
         
Other
             
   
Common
   
excess of
   
Retained
   
Comprehensive
   
Noncontrolling
       
   
stock
   
par value
   
earnings
   
Loss
   
interest
   
Total
 
Balance at December 31, 2012
  $ 13,095     $ 94,470     $ 215,390     $ (41,855 )   $ 8,576     $ 289,676  
Net income
                13,619             572       14,191  
Amounts reported in other comprehensive loss
                      108       (133 )     (25 )
Dividends ($0.245 per share)
                (3,219 )                 (3,219 )
Share issuance and equity-based compensation plans
    45       936                         981  
Excess tax benefit from stock option exercises
          369                         369  
Balance at March 31, 2013
  $ 13,140     $ 95,775     $ 225,790     $ (41,747 )   $ 9,015     $ 301,973  
                                                 
Balance at December 31, 2011
  $ 12,912     $ 89,725     $ 180,710     $ (28,967 )   $ 6,977     $ 261,357  
Net income
                12,365             747       13,112  
Amounts reported in other comprehensive income
                      4,988       291       5,279  
Dividends ($0.24 per share)
                (3,114 )                 (3,114 )
Share issuance and equity-based compensation plans
    39       (141 )                       (102 )
Excess tax benefit from stock option exercises
          1,252                         1,252  
Balance at March 31, 2012
  $ 12,951     $ 90,836     $ 189,961     $ (23,979 )   $ 8,015     $ 277,784  


 
15

Quaker Chemical Corporation
Notes to Condensed Consolidated Financial Statements - Continued
(Dollars in thousands, except per share amounts)
(Unaudited)


The following tables show the reclassifications from and resulting balances of accumulated other comprehensive loss at March 31, 2013 and March 31, 2012:
 
                     
Unrealized
       
   
Currency
   
Defined
   
Change in
   
gain (loss) in
       
   
translation
   
benefit
   
fair value of
   
available-for-
       
   
adjustments
   
pension plans
   
derivatives
   
sale securities
   
Total
 
Balance at December 31, 2012
  $ 3,336     $ (46,914 )   $     $ 1,723     $ (41,855 )
                                         
Other comprehensive (loss) income before reclassifications
    (1,630 )     762             1,148       280  
Amounts reclassified from accumulated other
                                       
comprehensive loss
          1,056             (494 )     562  
                                         
Current period other comprehensive (loss) income
    (1,630 )     1,818             654       842  
Related tax amounts
          (512 )           (222 )     (734 )
                                         
Net current period other comprehensive (loss) income
    (1,630 )     1,306             432       108  
                                         
Balance at March 31, 2013
  $ 1,706     $ (45,608 )   $     $ 2,155     $ (41,747 )
                                         
Balance at December 31, 2011
  $ 4,709     $ (34,260 )   $ (272 )   $ 856     $ (28,967 )
                                         
Other comprehensive income (loss) before reclassifications
    3,757       (562 )     (10 )     1,837       5,022  
Amounts reclassified from accumulated other
                                       
comprehensive loss
          750       158       (203 )     705  
                                         
Current period other comprehensive income
    3,757       188       148       1,634       5,727  
Related tax amounts
          (131 )     (52 )     (556 )     (739 )
                                         
Net current period other comprehensive income
    3,757       57       96       1,078       4,988  
                                         
Balance at March 31, 2012
  $ 8,466     $ (34,203 )   $ (176 )   $ 1,934     $ (23,979 )

Approximately 30% and 70% of the amounts reclassified from accumulated other comprehensive loss to the Condensed Consolidated Statement of Income for defined benefit retirement plans are recorded in cost of goods sold and selling, general and administrative expenses, respectively. See Note 12 of Notes to Condensed Consolidated Financial Statements for further information.  All reclassifications are recorded in interest expense for changes in fair value of derivatives and, also, reclassifications related to unrealized gain (loss) in available-for-sale securities relate to the Company’s equity interest in a captive insurance company and are recorded in equity in net income of associated companies.  The amounts reported in other comprehensive income for non-controlling interest are related to currency translation adjustments.
 
Note 10 – Business Acquisitions
 
In January 2013, the Company acquired a distribution network for its chemical milling maskants business related to its Coatings segment for net consideration of approximately $647.  The Company also assumed an additional $100 hold-back of consideration liability to be paid to the former owners at one year from the acquisition date.  The acquired intangible was included with the Company’s customer lists and rights to sell intangible assets and will be amortized over 5 years.
 
In July 2012, the Company acquired NP Coil Dexter Industries, S.r.l. for approximately $2,748, including short-term debt and long-term debt of approximately $1,186 and $854, respectively.  NP Coil Dexter is a European manufacturer and supplier of metal surface treatment products.  The Company allocated $3,825 of intangible assets, comprised of trademarks and formulations, to be amortized over 10 years; two customer lists to be amortized over 8 and 4 years, respectively; and a non-competition agreement to be amortized over 5 years.  In addition, the Company recorded $1,786 of goodwill, none of which will be tax deductible and was assigned to the metalworking process chemical segment.  Liabilities assumed include a hold-back of consideration to be paid to the former shareholders at eighteen months from the acquisition date.   During the fourth quarter of 2012, the Company recorded an increase to other income of approximately $1,033 on its Consolidated Statement of Income related to a change in the fair value of this hold-back of consideration liability.
 

 
16

Quaker Chemical Corporation
Notes to Condensed Consolidated Financial Statements - Continued
(Dollars in thousands, except per share amounts)
(Unaudited)


The following table shows the allocation of the purchase price of the assets and liabilities:
 
   
NP Coil Dexter
 
   
Industries, S.r.l.
 
Current assets
  $ 5,536  
Fixed assets
    1,211  
Intangibles
    3,825  
Goodwill
    1,786  
Other long-term assets
    783  
Total assets purchased
    13,141  
Short-term debt
    (1,186 )
Other current liabilities
    (6,168 )
Long-term debt
    (854 )
Other long-term liabilities
    (1,258 )
Present value of hold-back
    (927 )
Total liabilities assumed
    (10,393 )
Cash paid for an acquisition
  $ 2,748  

Included in the 2012 acquisition of NP Coil Dexter Industries, S.r.l. was approximately $113 of cash acquired.  Certain pro forma and other disclosures may not have been provided for this acquisition because the effects were not material.
 
Note 11 – Goodwill and Other Intangible Assets
 
The changes in carrying amount of goodwill for the three months ended March 31, 2013 are as follows and the Company has recorded no impairment charges in the past:

   
Metalworking
             
   
Process
             
   
Chemicals
   
Coatings
   
Total
 
Balance as of December 31, 2012
  $ 51,088     $ 8,081     $ 59,169  
Currency translation adjustments
    79             79  
Balance as of March 31, 2013
  $ 51,167     $ 8,081     $ 59,248  

Gross carrying amounts and accumulated amortization for definite-lived intangible assets as of March 31, 2013 and December 31, 2012 are as follows:

   
Gross Carrying
   
Accumulated
 
   
Amount
   
Amortization
 
   
2013
   
2012
   
2013
   
2012
 
Amortized intangible assets
                       
Customer lists and rights to sell
  $ 33,371     $ 32,356     $ 8,684     $ 8,192  
Trademarks and patents
    6,778       6,760       2,732       2,548  
Formulations and product technology
    5,278       5,278       3,501       3,423  
Other
    5,463       5,467       4,101       3,989  
Total
  $ 50,890     $ 49,861     $ 19,018     $ 18,152  

The Company recorded $879 and $746 of amortization expense in the three months ended March 31, 2013 and March 31, 2012, respectively. Estimated annual aggregate amortization expense for the current year and subsequent five years is as follows:

For the year ended December 31, 2013
  $ 3,395  
For the year ended December 31, 2014
  $ 3,164  
For the year ended December 31, 2015
  $ 3,164  
For the year ended December 31, 2016
  $ 2,684  
For the year ended December 31, 2017
  $ 2,030  
For the year ended December 31, 2018
  $ 2,014  

The Company has two indefinite-lived intangible assets totaling $1,100 for trademarks at March 31, 2013.

 
17

Quaker Chemical Corporation
Notes to Condensed Consolidated Financial Statements - Continued
(Dollars in thousands, except per share amounts)
(Unaudited)



Note 12 – Pension and Other Postretirement Benefits
 
The components of net periodic benefit cost for the three months ended March 31, 2013 and March 31, 2012 are as follows:

   
Three Months Ended March 31,
 
               
Other
 
               
Postretirement
 
   
Pension Benefits
   
Benefits
 
   
2013
   
2012
   
2013
   
2012
 
Service cost
  $ 838     $ 624     $ 13     $ 4  
Interest cost and other
    1,380       1,470       56       71  
Expected return on plan assets
    (1,478 )     (1,375 )            
Actuarial loss amortization
    981       691       47       31  
Prior service cost amortization
    28       28              
Net periodic benefit cost
  $ 1,749     $ 1,438     $ 116     $ 106  

Employer Contributions:
 
The Company previously disclosed in its financial statements for the year ended December 31, 2012, that it expected to make minimum cash contributions of $6,610 to its pension plans and $719 to its other postretirement benefit plan in 2013. As of March 31, 2013, $4,130 and $232 of contributions have been made to the Company’s pension plans and its postretirement benefit plans, respectively.
 
Note 13 – Commitments and Contingencies
 
In April of 1992, the Company identified certain soil and groundwater contamination at AC Products, Inc. (“ACP”), a wholly owned subsidiary. In voluntary coordination with the Santa Ana California Regional Water Quality Board (“SACRWQB”), ACP has been remediating the contamination, the principal contaminant of which is perchloroethylene (“PERC”). On or about December 18, 2004, the Orange County Water District (“OCWD”) filed a civil complaint in Superior Court in Orange County, California against ACP and other parties potentially responsible for groundwater contamination. OCWD was seeking to recover compensatory and other damages related to the investigation and remediation of the contamination in the groundwater. Effective October 17, 2007, ACP and OCWD settled all claims related to this litigation. Pursuant to the settlement agreement with OCWD, ACP agreed to pay $2,000.  In addition to the $2,000 payment, ACP agreed to operate the two existing groundwater treatment systems associated with its extraction wells P-2 and P-3 so as to hydraulically contain groundwater contamination emanating from ACP’s site until such time as the concentrations of PERC are below the current Federal maximum contaminant level for four consecutive quarterly sampling events. On September 11, 2012, ACP received a letter from the SACRWQB advising that no further action is required to remediate the soil contamination on site.  As of March 31, 2013, the Company believes that the range of potential-known liabilities associated with the ACP water remediation program is approximately $600 to $1,000, for which the Company has sufficient reserves.
 
The low and high ends of the range are based on the length of operation of the two extraction wells as determined by groundwater modeling with planned higher maintenance costs in later years if a longer treatment period is required. Costs of operation include the operation and maintenance of the extraction wells, groundwater monitoring and program management. The duration of the well operation was estimated based on historical trends in concentrations in the monitoring wells within the proximity of the applicable extraction wells. Also factored into the model was the impact of water injected into the underground aquifer from a planned water treatment system to be installed by OCWD adjacent to P-2. Based on the modeling, it is estimated that P-2 will operate for another one and one-quarter to two and three-quarter years and P-3 will operate for another three months. Operation and maintenance costs were based on historical expenditures and estimated inflation. As mentioned above, a significantly higher maintenance expense was factored into the range if the system operates for the longer period.
 
The Company believes, although there can be no assurance regarding the outcome of other unrelated environmental matters, that it has made adequate accruals for costs associated with other environmental problems of which it is aware. Approximately $245 and $230 was accrued at March 31, 2013 and December 31, 2012, respectively, to provide for such anticipated future environmental assessments and remediation costs.
 
An inactive subsidiary of the Company that was acquired in 1978 sold certain products containing asbestos, primarily on an installed basis, and is among the defendants in numerous lawsuits alleging injury due to exposure to asbestos. The subsidiary discontinued operations in 1991 and has no remaining assets other than the proceeds from insurance settlements received.  To date, the overwhelming majority of these claims have been disposed of without payment and there have been no adverse judgments against the subsidiary. Based on a continued analysis of the existing and anticipated future claims against this subsidiary, it is currently projected that the subsidiary’s total liability over the next 50 years for these claims is approximately $3,300 (excluding costs of defense). Although the Company has also been named as a defendant in certain of these cases, no claims have been actively pursued against the Company, and the Company has not contributed to the defense or settlement of any of these cases pursued against the subsidiary.
 

 
18

 
Table of Contents
Quaker Chemical Corporation
Notes to Condensed Consolidated Financial Statements - Continued
(Dollars in thousands, except per share amounts)
(Unaudited)


These cases were handled by the subsidiary’s primary and excess insurers who had agreed in 1997 to pay all defense costs and be responsible for all damages assessed against the subsidiary arising out of existing and future asbestos claims up to the aggregate limits of the policies. A significant portion of this primary insurance coverage was provided by an insurer that is now insolvent, and the other primary insurers have asserted that the aggregate limits of their policies have been exhausted. The subsidiary challenged the applicability of these limits to the claims being brought against the subsidiary. In response, two of the three carriers entered into separate settlement and release agreements with the subsidiary in late 2005 and early 2007 for $15,000 and $20,000, respectively.  The proceeds of both settlements are restricted and can only be used to pay claims and costs of defense associated with the subsidiary’s asbestos litigation. During the third quarter of 2007, the subsidiary and the remaining primary insurance carrier entered into a Claim Handling and Funding Agreement, under which the carrier will pay 27% of defense and indemnity costs incurred by or on behalf of the subsidiary in connection with asbestos bodily injury claims for a minimum of five years beginning July 1, 2007. The agreement continues until terminated and can only be terminated by either party by providing the other party with a minimum of two years prior written notice.  As of March 31, 2013, no notice of termination has been given under this agreement.  At the end of the term of the agreement, the subsidiary may choose to again pursue its claim against this insurer regarding the application of the policy limits. The Company also believes that, if the coverage issues under the primary policies with the remaining carrier are resolved adversely to the subsidiary and all settlement proceeds were used, the subsidiary may have limited additional coverage from a state guarantee fund established following the insolvency of one of the subsidiary’s primary insurers. Nevertheless, liabilities in respect of claims may exceed the assets and coverage available to the subsidiary.
 
If the subsidiary’s assets and insurance coverage were to be exhausted, claimants of the subsidiary may actively pursue claims against the Company because of the parent-subsidiary relationship. Although asbestos litigation is particularly difficult to predict, especially with respect to claims that are currently not being actively pursued against the Company, the Company does not believe that such claims would have merit or that the Company would be held to have liability for any unsatisfied obligations of the subsidiary as a result of such claims. After evaluating the nature of the claims filed against the subsidiary and the small number of such claims that have resulted in any payment, the potential availability of additional insurance coverage at the subsidiary level, the additional availability of the Company’s own insurance and the Company’s strong defenses to claims that it should be held responsible for the subsidiary’s obligations because of the parent-subsidiary relationship, the Company believes it is not probable that the Company will incur any material losses. All of the asbestos cases pursued against the Company challenging the parent-subsidiary relationship are in the early stages of litigation. The Company has been successful to date having claims naming it dismissed during initial proceedings. Since the Company may be in this early stage of litigation for some time, it is not possible to estimate additional losses or range of loss, if any.
 
As initially disclosed in the Company’s second quarter 2010 Form 10-Q, one of the Company’s subsidiaries may have paid certain value-added-taxes (“VAT”) incorrectly and, in certain cases, may not have collected sufficient VAT from certain customers.  The VAT rules and regulations at issue are complex, vary among the jurisdictions and can be contradictory, in particular as to how they relate to the subsidiary’s products and to sales between jurisdictions.
 
Since its inception, the subsidiary had been consistent in its VAT collection and remittance practices and had never been contacted by any tax authority relative to VAT. Now the subsidiary has determined that for certain products, a portion of the VAT was incorrectly paid and that the total VAT due exceeds the amount originally collected and remitted by the subsidiary.  In 2010, three jurisdictions contacted the subsidiary and, since then, the subsidiary has either participated in an amnesty program or entered into a settlement whereby it paid a reduced portion of the amounts owed in resolution of those jurisdictions’ claims.  The subsidiary has modified its VAT invoicing and payment procedures to eliminate or mitigate future exposure.
 
In analyzing the subsidiary’s exposure, it is difficult to estimate both the probability and the amount of any potential liabilities due to a number of factors, including: the decrease in exposure over time due to applicable statutes of limitations and actions taken by the subsidiary, the joint liability of customers and suppliers for a portion of the VAT, the availability of a VAT refund for VAT incorrectly paid through an administrative process, any amounts which may have been or will be paid by customers, as well as the timing and structure of any tax amnesties or settlements.  In addition, interest and penalties on any VAT due can be a multiple of the base tax. The subsidiary may contest any tax assessment administratively and/or judicially for an extended period of time, but may ultimately resolve its disputes through participation in tax amnesty programs, which are a common practice for settling tax disputes in the jurisdictions in question and which have historically occurred on a regular basis, resulting in significant reductions of interest and penalties. Also, the timing of payments and refunds of VAT may not be contemporaneous, and, if additional VAT is owed, it may not be fully recoverable from customers. As a result, this matter has the potential to have a material adverse impact on the Company’s financial position, liquidity and capital resources and the results of operations.
 
In 2010, the Company recorded a net charge of $4,132, which consisted of a net $3,901 charge related to two tax dispute settlements entered into by the subsidiary, as well as a net $231 charge representing management’s best estimate based on the information available to it, including the factors noted above, of the amount that ultimately may be paid related to the other jurisdiction that has made inquiries.  At March 31, 2013 and December 31, 2012, the Company had no accrual for remaining payments to be made under tax dispute settlements entered into by the subsidiary, as the respective accruals noted above were paid.
 
The charges taken by the Company in 2010 assume a successful recovery of the VAT incorrectly paid, as well as reductions in interest and penalties from anticipated future amnesty programs or settlements.  On a similar basis, if all other potentially impacted
 

 
19

 
Table of Contents
Quaker Chemical Corporation
Notes to Condensed Consolidated Financial Statements - Continued
(Dollars in thousands, except per share amounts)
(Unaudited)


jurisdictions were to initiate audits and issue assessments, the remaining exposure, net of refunds, could be from $0 to $12,500 with one jurisdiction representing approximately 82 percent of this additional exposure, assuming the continued availability of future amnesty programs or settlements to reduce the interest and penalties.  If there are future assessments but no such future amnesty programs or settlements, the potential exposure could be higher.
 
The Company is party to other litigation which management currently believes will not have a material adverse effect on the Company’s results of operations, cash flows or financial condition.
 
Note 14 – Subsequent Events
 
During 2002 and 2003, the Company’s Netherlands and Italian subsidiaries paid excise taxes on mineral oil sales in Italy for a total amount of approximately $2,000.  Alleging that the mineral oil excise tax was contrary to European Union directives, the subsidiaries filed with the Customs’ Authority of Milan (“Customs Office” or “Office”) requests to obtain a refund of the above-mentioned amount.  The parties appealed rulings to various levels of tax courts up through the Supreme Court of Italy.  In March 2012, the Supreme Court rejected the appeal of the Customs Office, ruling in favor of the subsidiaries and granting a refund for the amounts requested.
 
After filing an enforcement action, the Company ultimately collected approximately $2,000 (excluding interest) in late April 2013.  This amount will be recorded as other income on the Company’s Condensed Consolidated Statement of Income in the second quarter of 2013.
 

 
20

 
Table of Contents


Management’s Discussion and Analysis of Financial Condition and Results of Operations.

Executive Summary
 
Quaker Chemical Corporation is a leading global provider of process fluids, chemical specialties, and technical expertise to a wide range of industries, including steel, aluminum, automotive, mining, aerospace, tube and pipe, cans, and others.  For nearly 100 years, Quaker has helped customers around the world achieve production efficiency, improve product quality, and lower costs through a combination of innovative technology, process knowledge, and customized services. Headquartered in Conshohocken, Pennsylvania USA, Quaker serves businesses worldwide with a network of dedicated and experienced professionals whose mission is to make a difference.
 
The Company’s revenue decrease of less than 1% in the first quarter of 2013 compared to the first quarter of 2012 was primarily caused by decreases due to foreign exchange rate translation of approximately $2.2 million, or approximately 1%, partially offset by a slight increase due to selling and price mix, while product volumes, including acquisitions, remained consistent with the first quarter of 2012.  Gross profit increased approximately $2.8 million, or approximately 5%, from the first quarter of 2012, with gross margin improving to 35.5% compared to 33.7% for the first quarter of 2012, which is reflective of the Company’s continuing initiative to restore its margins to more acceptable levels.  Selling, general and administrative expenses (“SG&A”) increased approximately $2.1 million compared to the first quarter of 2012, primarily related to increases due to acquisitions, higher incentive compensation and higher selling, inflationary and other labor related costs which were partially offset by a decrease in foreign exchange rate translation.
 
During the first quarter of 2013, the Company’s net cash provided by operating activities was approximately $11.3 million, up from $6.7 million for the first quarter of 2012 on improved working capital management and the Company’s first dividend distribution from its captive insurance equity affiliate of $2.0 million.
 
The net result was an increase in earnings per diluted share from $0.95 for the first quarter of 2012 to $1.04 for the first quarter of 2013, with non-GAAP earnings per diluted share increasing from $0.91 for the first quarter of 2012 to $0.96 for the first quarter of 2013.   See Non-GAAP Measures section in this Item below.  Overall, the Company is encouraged by its solid performance in the first quarter of 2013 given the significant challenges it has faced in the global economic environment.  The Company’s market share gains and recent acquisitions have contributed to its relatively stable volumes and revenues, despite weak conditions in numerous parts of the world, especially in Europe.  The Company’s balance sheet and cash flow generation remain very strong, as its cash position exceeded its debt at March 31, 2013 and December 31, 2012, which provides financial flexibility for the Company to be able to invest in strategic growth opportunities, including acquisitions.   Going forward, the Company believes it will continue to face challenging market conditions around the world, with Europe continuing to be the most pronounced.  However, the Company remains optimistic about its future and still expects 2013 to be another good year for Quaker.
 
CMS Discussion

The Company currently has numerous CMS contracts around the world.  Under its traditional CMS approach, the Company effectively acts as an agent, and the revenues and costs from these sales are reported on a net sales or “pass-through” basis.  Under an alternative structure for certain contracts, the contracts are structured differently in that the Company’s revenue received from the customer is a fee for products and services provided to the customer, which are indirectly related to the actual costs incurred.  Profit is dependent on how well the Company controls product costs and achieves product conversions from other third-party suppliers’ products to its own products.  As a result, under the alternative structure, the Company recognizes in reported revenue the gross revenue received from the CMS site customer and in cost of goods sold the third-party product purchases, which substantially offset each other until the Company achieves significant product conversions. This may result in a decrease in reported gross margin as a percentage of sales.
 
The Company has maintained a mix of CMS contracts with both the traditional product pass-through structure and the alternative structure, including fixed price contracts that cover all services and products.  Since the global economic downturn and its impact on the automotive sector, the Company has experienced shifts in customer requirements and business circumstances, but the Company’s offerings continue to include both approaches to CMS.
 
Liquidity and Capital Resources

Quaker’s cash and cash equivalents increased to $35.3 million at March 31, 2013 from $32.5 million at December 31, 2012.  The $2.8 million increase was the result of $11.3 million of cash provided by operating activities, partially offset by $3.3 million of cash used in investing activities, $4.7 million of cash used in financing activities and a $0.5 million decrease from the effect of exchange rates on cash.
 
Net cash flows provided by operating activities were $11.3 million in the first quarter of 2013 compared to $6.7 million provided by operating activities in the first quarter of 2012.  The $4.6 million increase in operating cash flow was primarily driven by improved working capital management and the Company’s first dividend distribution from its captive insurance equity affiliate of $2.0 million.
 

 
21

 
Table of Contents

Net cash flows used in investing activities were $3.3 million in the first quarter of 2013 compared to $2.6 million used in investing activities in the first quarter of 2012.  The $0.7 million increase in cash used in investing activities was primarily the result of a payment in the first quarter of 2013 to acquire a chemical milling maskants distribution network for the Company’s coatings segment.  Lower cash inflow from a change in the Company’s restricted cash due to timing of claims and payments associated with a subsidiary’s asbestos litigation were partially offset by a decrease in investments in property, plant and equipment.  Lower investments in the Company’s information technology infrastructure in the first quarter of 2013 were partially offset by increased investments in its Asia/Pacific facilities.
 
Net cash flows used in financing activities were $4.7 million in the first quarter of 2013 compared to $2.7 million of cash used in financing activities in the first quarter of 2012.  For the first quarter of 2013, the Company was able to fund its investing and financing activities through strong net operating cash flow, and, also, repay a portion of its revolving credit line, compared to net borrowings during the first quarter of 2012.  During the first quarters of 2013 and 2012, the Company recorded $0.4 million and $0.5 million of respective excess tax benefits related to stock option exercises as cash flows from financing activities on its Condensed Consolidated Statement of Cash Flows.  Also, changes in stock option exercise and other related activity affected the financing cash flow comparisons.
 
The Company’s primary credit line is a $175.0 million syndicated multicurrency credit agreement with Bank of America, N.A. (administrative agent) and certain other major financial institutions, which expires in June 2014. At the Company’s option, the principal amount available can be increased to $225.0 million if the lenders agree to increase their commitments and the Company satisfies certain conditions.  At March 31, 2013 and December 31, 2012, the Company had approximately $10.0 million and $12.2 million, respectively, outstanding under this facility.  The Company’s access to this credit is largely dependent on its consolidated leverage ratio covenant, which cannot exceed 3.50 to 1. At March 31, 2013 and December 31, 2012, the consolidated leverage ratio was below 1.0 to 1.
 
At March 31, 2013, the Company’s gross liability for uncertain tax positions, including interest and penalties, was $14.4 million. The Company cannot determine a reliable estimate of the timing of cash flows by period related to its uncertain tax position liability. However, should the entire liability be paid, the amount of the payment may be reduced by up to $9.9 million as a result of offsetting benefits in other tax jurisdictions.
 
The Company believes it is capable of supporting its operating requirements, including pension plan contributions, payments of dividends to shareholders, possible acquisitions and business opportunities, capital expenditures and possible resolution of contingencies, through internally generated funds supplemented with debt or equity as needed.
 
Non-GAAP Measures
 
Included in this Form 10-Q filing is a non-GAAP financial measure of non-GAAP earnings per diluted share.  The Company believes this non-GAAP financial measure provides meaningful supplemental information as it enhances a reader’s understanding of the financial performance of the Company, is more indicative of future operating performance of the Company, and facilitates a better comparison among fiscal periods, as the non-GAAP measure excludes items that are not considered core to the Company’s operations.  Non-GAAP results are presented for supplemental informational purposes only and should not be considered a substitute for the financial information presented in accordance with GAAP.
 
The following is a reconciliation between the non-GAAP (unaudited) financial measure of non-GAAP earnings per diluted share to its most directly comparable GAAP (unaudited) measure:

   
Three Months Ended
 
   
March 31,
 
   
2013
   
2012
 
GAAP earnings per diluted share attributable to Quaker Chemical Corporation Common Shareholders
  $ 1.04     $ 0.95  
                 
Devaluation of the Venezuelan Bolivar per diluted share
    0.03        
Equity income in a captive insurance company per diluted share
    (0.11 )     (0.04 )
                 
Non-GAAP earnings per diluted share attributable to Quaker Chemical Corporation Common Shareholders
  $ 0.96     $ 0.91  

Out of Period Adjustment
 
As previously disclosed in the Company’s 2012 Annual Report on Form 10-K, the Company had reassessed its ability to significantly influence the operating and financial policies of its captive insurance equity affiliate, Primex.  Based on its ownership percentage and other factors, the Company determined that, during 2012, the Company obtained the ability to significantly influence Primex and, as a result, changed its method of accounting from the cost to equity method.   During the first quarter of 2013, the Company identified errors in Primex’s estimated 2012 financial statements, which primarily related to a reinsurance contract held by
 

 
22

 
Table of Contents

Primex.  The identified errors resulted in a cumulative $1.0 million understatement of the Company’s equity in net income from associated companies for the year ended December 31, 2012.  The Company corrected the errors related to Primex in the first quarter of 2013, which had the net effect of increasing equity in net income from associated companies by $1.0 million for the three months ended March 31, 2013.  The Company does not believe this adjustment is material to the consolidated financial statements for the year ended December 31, 2012 or to the Company’s projected results for the current year and, therefore, has not restated any prior period amounts.  As the Company’s assessment was based on projected full year 2013 results, the Company will update its assessment at year-end based upon actual 2013 results.  See Note 2 of Notes to Condensed Consolidated Financial Statements.
 
Operations
 
Comparison of the First Quarter of 2013 with the First Quarter of 2012
 
Net sales for the first quarter of 2013 were $176.2 million, a decrease of less than 1% from $177.6 million in the first quarter of 2012.  Foreign exchange rate translation decreased revenues by approximately $2.2 million, or 1%, which was partially offset by a slight increase due to selling and price mix of less than 1%.  Product volumes, including acquisitions, were consistent in the first quarter of 2013 compared to the first quarter of 2012.
 
Gross profit increased approximately $2.8 million, or approximately 5%, from the first quarter of 2012.  The increase in gross profit on consistent sales was due to an improvement in gross margin to 35.5% compared to 33.7% for the first quarter of 2012 and 34.2% for the fourth quarter of 2012.  The increase in gross margin is reflective of the Company’s continuing initiative to restore its margins to more acceptable levels.
 
SG&A increased approximately $2.1 million compared to the first quarter of 2012, primarily related to increases due to acquisitions, higher incentive compensation and higher selling, inflationary and other labor related costs which were partially offset by a decrease in foreign exchange rate translation.
 
The decrease in interest expense was due to lower average borrowings and lower interest rates experienced in the first quarter of 2013 as compared to the first quarter of 2012.
 
The Company’s effective tax rates for the first quarters of 2013 and 2012 of 24.1% and 21.5%, respectively, reflect decreases in reserves for uncertain tax positions due to the expiration of applicable statutes of limitations for certain tax years of approximately $0.10 and $0.12 per diluted share, respectively.  Also, contributing to the difference in the effective tax rate is that the tax rate in China was 15% in 2012 compared to 25% in the first quarter of 2013.  While the Company's re-certification of its Chinese subsidiary as a high tech enterprise is pending, the Company will record tax expense at the statutory rate of 25%.  The Company has experienced and expects to further experience volatility in its effective tax rates due to the varying timing of tax audits and the expiration of applicable statutes of limitations as they relate to uncertain tax positions, among other factors.  The Company estimates that its full year 2013 effective tax rate will be in the high twenty percent range, as compared to the lower rate experienced in the first quarter of 2013.
 
The increase in equity in net income of associated companies was primarily due to higher earnings related to the Company’s equity interest in a captive insurance company in the first quarter of 2013 compared to the first quarter of 2012 of $0.11 and $0.04 per diluted share, respectively, which includes the net effect of the out of period adjustment discussed above.  This increase was partially offset by a charge of approximately $0.03 per diluted share related to the devaluation of the Venezuelan Bolivar Fuerte during the first quarter of 2013. See Note 1 of Notes to Condensed Consolidated Financial Statements.
 
Changes in foreign exchange rates negatively impacted the first quarter of 2013 net income by approximately $0.1 million or $0.01 per diluted share.
 
Segment Reviews—Comparison of the First Quarter of 2013 with the First Quarter of 2012
 
Metalworking Process Chemicals
 
Metalworking Process Chemicals generally consists of industrial process fluids for various heavy industrial and manufacturing applications.  This segment represented approximately 93% of the Company’s first quarter of 2013 net sales, which were down approximately $1.0 million, or 1%, compared to the first quarter of 2012.   Net sales for this reportable segment increased less than 1% from price and selling mix, which was offset by a decrease of approximately 1% due to foreign currency translation.   The foreign currency translation impacts were primarily driven by the average Brazilian Real to U.S. Dollar exchange rate being 0.50 in the first quarter of 2013 compared to 0.57 in the first quarter of 2012.   Product volumes, including acquisitions, were consistent in the first quarter of 2013 compared to the first quarter of 2012.  The first quarter of 2013 operating income for this reportable segment increased approximately $1.1 million from the first quarter of 2012, which was driven by the Company’s continuing initiative to restore its margins to more acceptable levels.
 

 
23

 
Table of Contents

Coatings
 
The Company’s coatings segment, which represented approximately 6% of the Company’s net sales in the first quarter of 2013, generally contains products that provide temporary and permanent coatings for metal and concrete products and chemical milling maskants.  Net sales for this reportable segment in the first quarter of 2013 were up approximately $0.2 million, or 2%, compared to the first quarter of 2012, which was primarily due to increased sales of chemical milling maskants to the aerospace industry.  The first quarter of 2013 operating income for this reportable segment was consistent with the first quarter of 2012, as additional earnings from the increase in milling maskants sales were offset by a change in the sales mix of other products with lower margins.
 
Other Chemical Products
 
Other Chemical Products, which represented approximately 1% of the Company’s net sales in the first quarter of 2013, consists of sulfur removal products for industrial gas streams sold by the Company’s Q2 Technologies joint venture.  For the first quarter of 2013, net sales and operating income decreased approximately $0.6 million and approximately $0.2 million, respectively, compared to the first quarter of 2012, due to lower activity in the oil and gas market.
 
Factors That May Affect Our Future Results
 
(Cautionary Statements Under the Private Securities Litigation Reform Act of 1995)

Certain information included in this Report and other materials filed or to be filed by Quaker with the SEC (as well as information included in oral statements or other written statements made or to be made by us) contain or may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements can be identified by the fact that they do not relate strictly to historical or current facts. We have based these forward-looking statements on our current expectations about future events. These forward-looking statements include statements with respect to our beliefs, plans, objectives, goals, expectations, anticipations, intentions, financial condition, results of operations, future performance and business, including:

·  
statements relating to our business strategy;
·  
our current and future results and plans; and
·  
statements that include the words “may,” “could,” “should,” “would,” “believe,” “expect,” “anticipate,” “estimate,” “intend,” “plan” or similar expressions.
 
Such statements include information relating to current and future business activities, operational matters, capital spending, and financing sources. From time to time, forward-looking statements are also included in Quaker’s other periodic reports on Forms 10-K, 10-Q and 8-K, as well as in press releases and other materials released to, or statements made to, the public.
 
 Any or all of the forward-looking statements in this Report and in any other public statements we make may turn out to be wrong. This can occur as a result of inaccurate assumptions or as a consequence of known or unknown risks and uncertainties. Many factors discussed in this Report will be important in determining our future performance. Consequently, actual results may differ materially from those that might be anticipated from our forward-looking statements.
 
We undertake no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise. However, any further disclosures made on related subjects in Quaker’s subsequent reports on Forms 10-K, 10-Q and 8-K should be consulted. These forward-looking statements are subject to risks, uncertainties and assumptions about us and our operations that are subject to change based on various important factors, some of which are beyond our control. A major risk is that the Company’s demand is largely derived from the demand for its customers’ products, which subjects the Company to uncertainties related to downturns in a customer’s business and unanticipated customer production shutdowns. Other major risks and uncertainties include, but are not limited to, significant increases in raw material costs, worldwide economic and political conditions, foreign currency fluctuations, terrorist attacks and other acts of violence. Furthermore, the Company is subject to the same business cycles as those experienced by steel, automobile, aircraft, appliance, and durable goods manufacturers. These risks, uncertainties, and possible inaccurate assumptions relevant to our business could cause our actual results to differ materially from expected and historical results. Other factors beyond those discussed could also adversely affect us. Therefore, we caution you not to place undue reliance on our forward-looking statements. This discussion is provided as permitted by the Private Securities Litigation Reform Act of 1995.

 
24

 
Table of Contents

Quantitative and Qualitative Disclosures About Market Risk.

 
We have evaluated the information required under this item that was disclosed in Part II, Item 7A of our Annual Report on Form 10-K for the year ended December 31, 2012, and we believe there has been no material change to that information.
 

 
25

 
Table of Contents

Controls and Procedures.

Evaluation of disclosure controls and procedures. As required by Rule 13a-15(b) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), our management, including our principal executive officer and principal financial officer, has evaluated the effectiveness of our disclosure controls and procedures as of the end of the period cover by this report.  Based on that evaluation, our principal executive officer and our principal financial officer have concluded that as of the end of the period covered by this report our disclosure controls and procedures (as defined in Rule 13a-15(e) under the Exchange Act) were effective.
 
Changes in internal control over financial reporting. As required by Rule 13a-15(d) under the Exchange Act, our management, including our principal executive officer and principal financial officer, has evaluated our internal control over financial reporting to determine whether any changes to our internal control over financial reporting occurred during the quarter ended March 31, 2013 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.  Based on that evaluation, no such changes to our internal control over financial reporting occurred during the quarter ended March 31, 2013.
 

 
26

 
Table of Contents

PART II. 
OTHER INFORMATION

Items 1A, 3, 4 and 5 of Part II are inapplicable and have been omitted.

Item 1.  Legal Proceedings

Incorporated by reference is the information in Note 13 of the Notes to the Condensed Consolidated Financial Statements in Part I, Item 1 of this Report.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

The following table sets forth information concerning shares of the Company’s common stock acquired by the Company during the period covered by this report, all of which were acquired from employees for payment of the exercise price of employee stock options exercised, for the payment of taxes upon exercise of employee stock options or for the vesting of restricted stock during the period.
 

               
(c)
   
(d)
 
               
Total Number of
   
Maximum
 
               
Shares Purchased as
   
Number of Shares that
 
   
(a)
   
(b)
   
Part of
   
May Yet
 
   
Total Number
   
Average
   
Publicly Announced
   
Be Purchased Under the
 
   
of Shares
   
Price Paid
   
Plans
   
Plans or
 
Period
 
Purchased (1)
   
Per Share (2)
   
or Programs (3)
   
Programs (3)
 
January 1 - January 31
    9,920     $ 57.79             252,600  
February 1 - February 29
        $             252,600  
March 1 - March 31
    1,301     $ 61.33             252,600